CIK 0001357874
- Non-accelerated filer
- Smaller reporting company
PRECISION BIOSCIENCES INC
Sign in to watch- Ticker
- DTIL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- May 21
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 919-314-5512
- Business address
- 302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
- Open-market buys, last 90 days
- $29,501
- in 3 filings
- Open-market sales, last 90 days
- $27,505
- in 1 filing, $28K under 10b5-1 plans
Net +$1,996. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-04-01 | Schinazi Raymond F Director | Conversion · Series B Preferred Stock | −119,761 | 0 | ||
| 2019-04-01 | venBio Global Strategic Fund, L.P. Director | Purchase | +50,000 | $16.00 | $800K | 50,000 |
| 2019-04-01 | venBio Global Strategic Fund, L.P. Director | Conversion | +3,747,623 | 3,797,623 | ||
| 2019-04-01 | venBio Global Strategic Fund, L.P. Director | Conversion | +467,518 | 4,265,141 | ||
| 2019-04-01 | venBio Global Strategic Fund, L.P. Director | Conversion · Series A Preferred Stock | −8,000,000 | 0 | ||
| 2019-04-01 | venBio Global Strategic Fund, L.P. Director | Conversion · Series B Preferred Stock | −998,004 | 0 | ||
| 2019-03-27 | YAO TONY DUNG LING Director | Other acquisition · Convertible Promissory Note | +0 | $500,000.00 | $0 | |
| 2019-03-27 | Schinazi Raymond F Director | Grant or award · Stock Option (Right to Buy) | +34,544 | 34,544 | ||
| 2019-03-27 | Schinazi Raymond F Director | Other acquisition · Convertible Promissory Note | +0 | $500,000.00 | $0 |
Page 28 of 28 · 549 trades